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Background. Neutrophils are the predominant cell in the lung inﬂammatory inﬁltrate of infants with
respiratory syncytial virus (RSV) bronchiolitis. Although it has previously been shown that neutrophils from both
blood and bronchoalveolar lavage (BAL) are activated, little is understood about their role in response to RSV
infection. This study investigated whether RSV proteins and mRNA are present in neutrophils from blood and BAL
of infected infants.
Methods. Weobtained bloodandBALsamples from20 infants with severe RSVbronchiolitis and 8 healthy control
infants. Neutrophil RSV F, G, and N proteins, RSV N genomic RNA, and messenger RNA (mRNA) were quantiﬁed.
Results. RSV proteins were found in BAL and blood neutrophils in infants with RSV disease but not in
neutrophils from healthy infants. BAL and blood neutrophils from infants with RSV disease, but not those from
healthy infants, expressed RSV N genomic RNA, indicating uptake of whole virus; 17 of 20 BAL and 8 of 9 blood
neutrophils from patients expressed RSV N mRNA.
Conclusions. This work shows, for the ﬁrst time, the presence of RSV proteins and mRNA transcripts within
BAL and blood neutrophils from infants with severe RSV bronchiolitis.
Bronchiolitis is the commonest cause of lower
respiratory tract infection in children under the age of 1
year [1]. Most cases are caused by respiratory syncytial
virus (RSV), of which there are 2 serotypes, A and B.
Serotype A is the most common serotype found in
United Kingdom (UK) seasonal epidemics, although
proportions vary annually [2]. The clinical manifes-
tations of RSV infection range from mild upper
respiratory tract symptoms, to severe lower respiratory
tract infection presenting as low-grade fever that can
progress over several days to coughing, wheezing,
shortness of breath, and difﬁculty with feeding. Al-
though some infants with bronchiolitis have clinical
symptoms beyond the lungs including otitis media,
myocardial failure, seizures, and hepatitis, [3] whether
these extrapulmonary manifestations are due to RSV
infection itself or to secondary effects is not fully un-
derstood. RSV RNA has been detected outside the lungs
incerebrospinalﬂuid[4],myocardium[5],andliver[6].
Human RSV is transmitted by inhalation of aero-
solized virus droplets to the airway epithelium [7],
a major site for viral replication. Infection is followed by
cytokine release and airway inﬂammation [8, 9]. The
surface glycoproteins RSV F and G facilitate binding of
the virus [10, 11] to their target cells whereas RSV
N protein is located inside the virion, tightly bound to
the genome. In vitro, RSV has been shown to infect
epithelial cells [12]), alveolar macrophages [13], den-
dritic cells [14, 15], and bone marrow stromal cells [16].
Infection of the epithelial cells promotes the release of
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[17]. Neutrophils are recruited early in the course of infection
and represent .80% of the inﬂammatory cell inﬁltrate in
bronchoalveolarlavage (BAL) at thepeak of the patient’sclinical
symptoms [17]. Neutrophils in the airways are highly activated
[20], release cytokines [21–24], and have delayed apoptosis [25,
26]. However, how they inﬂuence RSV clearance or viral repli-
cation within the human airway remains largely unknown.
The aim of this study was to determine whether RSV directly
interacts with, or indeed infects, infant neutrophils in the lung
and peripheral circulation, by measuring RSV protein and gene
transcript expression in neutrophils from the blood and BAL of
infants with severe RSV bronchiolitis.
PATIENTS AND METHODS
Study Population, Sample Collection, and Preparation
We recruited 20 infants who were aged ,18 months and ad-
mitted with severeRSV bronchiolitis to the intensive care unit at
AlderHeyChildren’sHospital.RSVbronchiolitiswasconﬁrmed
by direct immunoﬂuorescence of nasopharyngeal aspirates. The
control group consisted of 8 uninfected healthy infants of
comparable age, ventilated prior to elective noncardiac surgery.
Infants with underlying cardiorespiratory disease were excluded.
Ages were corrected for prematurity. Blood and BAL samples
were collectedand prepared as described in previous studies [17,
18, 20] as soon as possible after intubation to minimize the
effects of mechanical ventilation on the airways (Table 1).
The Liverpool Paediatric Research Ethics Committee approved
the study and parents/guardians of participants gave full written
consent for study procedures.
Enrichment of BAL and Preparation of Blood Neutrophils
As described previously [20], BAL was ﬁltered through a 60-lm
pore size gauze (Sefar Nitex 03-48/31) to remove bulk mucous
and then centrifuged. The supernatant was removed and cells
were resuspended in RPMI 1640. Neutrophils were then en-
riched using a sedimentation gradient of Polymorphprep
(Axis-Shield PoC AS Norway) as directed by the manufacturer.
After centrifugation, cells were resuspended and washed in
RPMI 1640 prior to staining. Blood samples were collected into
heparinized tubes and blood neutrophils prepared as stated
above on a Polymorphprep sedimentation gradient prior to
analysis.
FACS Analysis: Protein Expression of RSV F, G, and N
For total expression of RSV, F, G, and N neutrophils were
permeabilized, ﬁxed (BD Cytoﬁx and Cytoperm, BD Bio-
sciences), and labeled. For cell surface expression only, cells were
Table 1. Characteristics of Patients and BAL and Blood Samples
Bronchiolitis infants Control infants
Clinical information
No. of infants (male) 20 (10) 8 (5)
No. preterm (male) 11 (5) 0
Age on admission, corrected for prematurity, in wk median (range) 10 (–5, 20) 12 (6, 20)
Weight on admission, kg mean (SEM) 3.8 (.45) 4.3 (2.0)
Gestation at birth, wk median (range) 38 (27, 42) 40 (37, 40)
BAL characteristics before enrichment
% viable cells mean (SEM) 95 (2.5) 95 (1)
Total cell count/mL mean (SEM) 1.85 (.7) 1.5 (.9)
% neutrophils median (IQR) 84 (2.5) 37 (3)
% alveolar macrophages median (IQR) 12.5 (1.5) 47 (3)
% lymphocytes median (IQR) 5 (.5) 7 (3)
BAL characteristics after enrichment using Polymorphprep
% viable cells mean (SEM) 93 (2) 94 (2)
% neutrophils median (IQR) 95 (2.5) 96 (2)
Blood characteristics before enrichment
% viable cells mean (SEM) 97 (2) 96 (1)
Neutrophils 3 10
9/L mean (SEM) 4.93 (1.46) 4.5 (1.56)
Monocytes 3 10
9/L mean (SEM) 0.99 (.15) 1.0 (.18)
Lymphocytes 3 10
9/L mean (SEM) 3.67 (.3) 3.63 (.35)
Eosinophils 3 10
9/L mean (SEM) 0.088 (.04) 0.082 (.045)
Blood characteristics after enrichment
% viable cells mean (SEM) 95 (2) 94 (1.5)
% neutrophils median (IQR) 96 (1.5) 95 (1)
NOTE. BAL, bronchoalveolar lavage; IQR, interquartile range; SEM, standard error of mean.
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initially using a primary test antibody, RSV F, G, or N (Acris
Antibodies), or isotype-matched control followed by a second-
ary antimouse ﬂuorescein isothiocyanate (FITC) secondary
antibody, a neutrophil marker (phycoerythrin [PE]–labeled
myeloperoxidase [MPO] or cluster density [CD] 16 separately),
and ethidium monoazide bromide (EMA; Biotium) to allow
exclusion of nonviable cells. Samples were analyzed on a FAC-
Sort ﬂow cytometer (Becton Dickinson) collecting a minimum
of 10000 events. All samples were analyzed with the same
voltage and gain settings during the study period. Calibration
beads were used to control for laser decay. The isotype control
was set in the ﬁrst decade to maximize sensitivity of samples.
Cells were deemed positivefor RSV proteins iftheir ﬂuorescence
was greater than the 95th percentile of the ﬂuorescence of the
matched isotype control. Positive values were calculated in each
case by subtracting the isotype control values, typically less than
1%, from the observed test values. Data were processed using
WinMDI software, version 2.9. Neutrophils were gated by size,
granularity, viability, and CD16 or MPO expression.
Cellular Localization of RSV Protein by Immunocytochemistry
Neutrophils were resuspended in 4% sucrose/paraformaldehyde
and air-dried onto slides. Slides were then stained for RSV
proteins using F, G, or N primary monoclonal antibodies, or
isotype-matched control antibodies, followed by a PE-labeled
secondary goat antimouse antibody and with the nuclear stain
DAPI. The slides were ﬁxed and visualized by ﬂuorescence
microscopy at 403 magniﬁcation. The RSV-infected Hep2
(multiplicity of infection, 0.25) cell line was used as a positive
control.
Real-Time-Polymerase Chain Reaction Quantification of RSV N
Genomic RNA and Messenger RNA
Genomic RNA and messenger RNA (mRNA) were measured
using Real-Time-Polymerase Chain Reaction (RT-PCR) and
Taqman primersforeither RSV N serotype A or RSV N serotype
B (Primer Design; catalog numbers Path-RSVA-std, Path-
RSVB-std, respectively). All PCR reactions were in triplicate
using an Applied Biosystems 7300 system and standardized to
the housekeeping gene L32 using the DCt method to give the
median logfold ratio. RNA from an RSV-infected Hep2 cell line
was used as a positive control and water was used as a negative
control.
Statistical Analysis
RSV protein (F, G, and N) and mRNA (N gene) expression was
studied in enriched neutrophil blood and BAL samples from
infants with RSV bronchiolitis and the control group. Data were
analyzed using independent samples t tests or Mann-Whitney
U tests depending on data distribution determined by the
1-sample Kolmogorov-Smirnov test. Differences in RSV protein
(F, G, and N) and mRNA (N gene) expression between blood
and BAL within participants from each patient group were
examined using paired t tests. Data were analyzed using SPSS 17
software (SPSS Inc).
RESULTS
RSV F, G, and N Proteins Are Expressed Both on and in BAL and
Blood Neutrophils From Infants With RSV Bronchiolitis
All samples from infants with RSV disease expressed RSV
p r o t e i n sF ,G ,a n dNo nb o t hB A La n db l o o dn e u t r o p h i l s .
Figure 1A shows representative histograms for the total and
cell surface expression of RSV proteins on BAL and blood
neutrophils from an infant with RSV disease and a healthy
control. RSV F, G, and N proteins were not expressed on BAL
or blood samples from healthy controls. For BAL neutrophils
from RSV-infected infants, the mean percentages (6SEM) of
neutrophils positive for RSV F, G, and N were 86.6 (2.8), 82.9
(3.2), and 83.8(2.9), respectively,with amedian (interquartile
range [IQR]) mean fluorescent intensity (MFI) compared
with isotype controls for RSV F, G, and N proteins of 56.9
(54.7), 52.0 (44.4), and 66.4 (37.6), respectively. For blood
neutrophils from RSV-infected infants, the mean percentages
(SEM) of neutrophils positive for RSV F, G, and N were 55.7
(2.9), 54.8 (4.7), and 54.0 (4.9), with a median (IQR) MFI
compared with isotype controls for RSV F, G, and N proteins
of 29.2 (59.5), 26.8 (50.0), and 27.4 (46.2), respectively
(Figures 1B and 1C). A signiﬁcantly greater proportion of the
BAL neutrophils from RSV-infected infants expressed RSV
proteins F, G, and N (P , .001) compared with blood neu-
trophils, and the levels of expression of these RSV proteins
in positive cells (as indicated by the MFI of the positive cells)
was signiﬁcantly different between BAL and blood (P 5 .013
and .012 for proteins G and N, respectively, but not for RSV
F protein[P5 .079]).Thisindicatesthatboththeproportionof
neutrophils expressing RSV proteins and the level of expression
of these proteins were greater in the lung than in the blood.
Because our monoclonal antibodies for FACS analysis were
not directly conjugated, it was not possible to determine the
absolute numbers of antibody binding sites per neutrophil for
each of the proteins. In order to gain some insight into the
stoichiometry of expression of RSV proteins F, G, and N in
neutrophils, the analysis shown in Figure 2 was performed.
These data show very strong correlations between the expression
of these individual proteins in both BAL and blood neutrophils
(all P , .001). These data thus demonstrate that levels of ex-
pression of all 3 viral proteins were proportionate to each other,
strongly indicating stoichiometric expression. This relationship
held when analyzing both the numbers of positive cells
(% positive) or the levels of expression (MFI).
Immunoﬂuorescence was used to conﬁrm the expression
of RSV proteins in neutrophils compared with RSV-infected
Hep2 cells, which were used as a positive control to assess the
Neutrophils in RSV Bronchiolitis d JID 2011:204 (1 August) d 453Figure 1. Respiratory syncytial virus (RSV) F, G, and N protein expression by bronchoalveolar lavage (BAL) and blood neutrophils from patient and
control samples. A, Flow cytometry analysis of total (black line) and cell surface expression only (gray line) of RSV protein binding to BAL or blood
454 d JID 2011:204 (1 August) d Halfhide et alspeciﬁcity of the antibodies. In non–RSV-infected Hep2 cells,
no positive staining was observed for RSV proteins F, G, or N
(data not shown), whereas strong positive staining was ob-
served in these cultured cells infected with RSV in vitro
(Figure 3). BAL patient neutrophils stained strongly for RSV
F, G, and N proteins (Figure 3).
RSV Genomic RNA and mRNA Is Detected in BAL and Blood
Neutrophils From Infants With RSV Bronchiolitis
PCR analysis was carried out after ﬂow cytometry on 20 of 20
BAL and 9 of 20 blood neutrophil samples from RSV-positive
infants, and 8 of 8 BAL and 5 of 8 blood neutrophil samples
from control infants (Table 2).
neutrophils from infants with and without RSV infection. Representative histograms are shown after gating for viable cells by ethidium monoazide
bromide staining, CD16 (a neutrophil marker), and respective anti-RSV monoclonals or isotype controls (shown shaded in gray). Numbers shown represent
the percentage of positive cellsabove isotype control values following permeabilization. B,Summary data forpercentage of positive cells foreach patient
(n 5 20) or controls (n 5 8). Each point represents an individual value, while the bar represents the sample mean. C, Summary data for mean
fluorescence intensity of each sample analyzed by FACS. Each point represents an individual sample value. The bar represents the median value. B and C,
the open dot highlights the corresponding data for the RSV-positive infant BAL neutrophils shown in Figure 3.
Figure 2. Correlation between expression of different RSV F, G, and N protein levels in BAL and blood neutrophils. A, Correlation in percentage of cells
positive between F (y-axis) and G (x-axis) (BAL r
2 5 .899, P ,.001; blood r
25 .96, P ,.001); F (y-axis) and N (x-axis) (BAL r
2 5 .835, P ,.001; blood
r
2 5 .982, P ,.001) and G (y-axis) and N (x-axis) (BAL r
2 5 .911, P ,.001; blood r
2 5 .957, P ,.001). Each point represents an individual sample value.
B, Correlation in mean fluorescence intensity (MFI) between F (y-axis) and G (x-axis) (BAL r
2 50.86, P ,.001; blood r
2 5.899, P ,.001); F (y-axis) and
N (x-axis) (BAL r
2 5 .86, P ,.001; blood r
2 5 .86, P ,.001) and G (y-axis) and N (x-axis) (BAL r
2 5 .83, P ,.001; blood r
2 5 .911, P ,.001). Each point
represents an individual sample.
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RSV-positive infants and no BAL or blood neutrophil samples
from control infants expressed genomic RSV N (serotype A).
Furthermore, 17 of 20 BAL neutrophils and 8 of 9 blood neu-
trophil samples from RSV-positive infants also expressed RSV N
mRNA (serotype A). For the RSV-positive infants, there was no
signiﬁcant difference in the levels of expression of mRNA for
RSV N (serotype A) compared with the housekeeping gene L32
between the blood and BAL compartments (P 5 .248); the
median logfold ratios of RSV N mRNA to L32 mRNA (6IQR)
were blood .2214 (68.047) and BAL .814 (614.185). Two
pairedblood and BAL samples showedthe presence of both RSV
N mRNA (serotype A and serotype B). No healthy control
samples were positive for genomic RNA or RSV N mRNA
(serotype B) (Table 2). DNA sequencing of PCR products
generated using RSV F, G, and NS1 primers conﬁrmed the
identity of the products as the RSV gene under study (data not
shown).
DISCUSSION
This is, to our knowledge, the ﬁrst clinical study to investigate
whether RSV interacts with neutrophils in infants with RSV
bronchiolitis. We show that RSV F, G, and N proteins are
present within the neutrophils from the airways of these infants
and make the novel and potentially important discovery that
these proteins are also expressed in the blood neutrophils of
these patients. Expression was determined by measuring protein
levels but also by measuring the levels of expression of the genes.
Furthermore, the presence of RSV mRNA in neutrophils
indicates that active transcription of the virus is likely to be
occurring.
Neutrophils are phagocytic cells and so it might be predicted
that viral proteins would be present within them. For example,
viral proteins could be present within neutrophils following
phagocytosis of virus-infected cells, possibly infected epithelial
cells or other neutrophils. Phagocytosis of apoptotic neutrophils
by other neutrophils has been demonstrated in vitro, and con-
tact with apoptotic cells inhibited the proinﬂammatory function
of neutrophils, suggesting that this process contributes to the
resolutionofinﬂammation[27].However,certainaspectsofour
ﬁndings suggest that phagocytosis by neutrophils is not the
explanation. The pattern of viral protein expression was of dif-
fuse cytoplasmic staining (Figure 3) rather than being localized
within phagocytic vesicles. If the viral particles entered by
phagocytosis into the denaturing, hostile environment of the
phagocytic vacuole, it is unlikely that we would have detected
any labile viral mRNA intact within neutrophils.
Our data show a strong correlation between the expression of
RSV F, G, and N proteins in neutrophils, which is indicative of
their stoichiometric expression. This suggests that intact viral
particles are present within neutrophils. These particles could
arise from uptake of whole virus by neutrophils, or intriguingly,
via replication of virus within the neutrophil. We have no direct
evidence for the latter possibility, but it is of note that we de-
tected RSV mRNA in both blood and BAL neutrophils. Al-
though this ﬁnding is suggestive of viral transcription, it does
not necessarily imply whole viral replication. The synthesis of
new viral particles requires the expression of antigenome, which
is only believed to occur transiently at very low levels during
viral replication [28]. Furthermore, active transcription could
also represent abortive replication. Experiments in airway epi-
thelial cells from the cotton rat have shown that RSV is capable
of abortive replication, characterized by transcription of in-
dividualviralgenesbutnosynthesisofviralprogeny[29].Inthis
case, RSV transcripts and protein accumulated and resulted in
an increased inﬂammatory response [30]. We can speculate that
if abortive replication of RSV occurs in neutrophils, it may have
2 important effects that will be detrimental to the host: ﬁrst, to
delay neutrophil apoptosis and therefore prolong RSV survival
[25, 26]; and second, to exacerbate lung damage by acting as
a proinﬂammatory stimulus for the release of cytokines and
chemokines.
A surprising and unexpected ﬁnding was the discovery that
blood neutrophils from RSV-infected infants expressed RSV
viral proteins and both genomic RNA and mRNA for RSV. In
human RSV infection, RSV RNA has been demonstrated in
Figure 3. Detection of RSV F, G, and N proteins within the cytoplasm of
neutrophils by immunofluorescence. A representative BAL sample (shown
in Figures 1B and 1C by an open dot with percentage of positive cells F,
G, and N [87, 80, 86, respectively] and MFI for F, G, and N [50, 43, 50,
respectively]) was stained with isotype control (IgG1 and IgG2a) or RSV-
specific F, G, and N monoclonal antibodies. Positive staining (PE) is shown
in red while nuclei that were counterstained by DAPI are shown in blue.
Table 2. Summary RT-PCR Data for RSV Genomic and mRNA for
RSV N
Cases Controls
RT-PCR RSV N; A and B serotypes Blood BAL Blood BAL
Genomic RSV A 9/9 20/20 0/5 0/8
mRNA RSV A 8/9 17/20 0/5 0/8
Genomic RSV B 2/9
a 2/20
a 0/5 0/8
mRNA RSV B 2/9
a 2/20
a 0/5 0/8
NOTE. BAL, bronchoalveolar lavage; RSV, respiratory syncytial virus; RT-
PCR, real-time polymerase chain reaction.
a Two of 20 RSV-positive infants expressed both RSV N gene genomic RNA
and messenger RNA for both serotypes A and B in both blood and BAL
neutrophils, indicating dual infection.
456 d JID 2011:204 (1 August) d Halfhide et alwhole blood [31], and RSV antigens [32] and RNA have been
found in circulating blood mononuclear leukocytes [33, 34] but
not, until now, in either blood or lung neutrophils. RSV has also
been demonstrated within the blood in a murine model of RSV
airway infection. In these experiments the time course of RSV
RNA detected in the blood was reported to mirror viral repli-
cation in the respiratory tract and peak disease severity [35]. It is
noteworthy that the RSV-infected infants in our study had se-
verebronchiolitis,requiringhospitalizationinintensivecareand
ventilation. It would be interesting now to determine if neu-
trophils from the blood of RSV-infected infants with less severe
bronchiolitis also express RSV proteins and RNA, or whether
this is restricted to the more severe cases.
Our novel ﬁndings raise an extremely important and as yet
unresolved question: How does RSV, or its proteins and mRNA
transcripts, enter blood neutrophils? If it is assumed that the
virus initially enters the nasal epithelium via inhalation of virus-
containing droplets, then there are a number of possibilities.
First, viral particles may be released from infected airway epi-
thelial cells and then enter the circulation, where they are taken
up by circulating neutrophils. Second, neutrophils may take up
the virus in the airway lumen and then recirculate back into the
bloodstream. Similar mechanisms for viral infection of the re-
spiratory tract and subsequent appearance in the circulation
have been proposed for inﬂuenza. As with RSV infection, H5N1
(avian inﬂuenza) infection is primarily localized to the re-
spiratory tract but also can be found at sites outside the lung in
severedisease [36]. Recentinvitroexperiments haveshownthat
H5N1 can be secreted by human lung microvascular endothelial
cells, which in vivo would lead to secretion into the systemic
circulation [37]. We have no direct evidence that RSV-infected
neutrophils transmigrate from the lung back into the circula-
tion; however, there is evidence in the literature that such
a process can occur in vivo. Buckley et al [38] showed that
neutrophils can reverse-transmigrate across an endothelial
monolayer, that is, initially move though a monolayer and then
migrate back. These reverse-transmigrated cells are character-
ized by distinctive cell surface marker expression (CD54
high,
CXCR1
low). Cells with this phenotype were identiﬁed during
reverse-migration experiments in vitro and were later found to
be present in the bloodstream of healthy individuals in low
numbers but at higher numbers in patients with systemic in-
ﬂammation. It would therefore be interesting to determine if the
RSV-positive neutrophils in RSV-infected infants are also
CD54
high,C X C R 1
low.
The mechanism by which RSV may enter neutrophils is un-
known. RSV F protein has been shown in vitro to be a ligand for
Toll-like receptor 4 (TLR4) on peripheral blood macrophages
[13]. We have recently reported decreased total TLR4 protein in
both blood and BAL neutrophils from infants with severe RSV
bronchiolitis. The decrease in total TLR4 was signiﬁcantly
greater in those infants born at full term compared with those
born before 37 weeks (preterm infants) [20]. Both groups with
RSV infection had signiﬁcantly less total TLR4 than control
healthy infants. For each infant with RSV infection, BAL and
blood total neutrophil TLR4 indirectly correlated with the per-
centage of BAL and blood neutrophils positive (respectively) for
each of the 3 RSV proteins F, G, and N. In vitro experiments
showed that the decrease in total neutrophil TLR4 was not due
to competitive binding. We speculate that neutrophil TLR4 RSV
interaction may play an important role in the pathogenesis of
severe RSV disease, especially in those infants born at full term.
In summary we have shown that neutrophils in the BAL and
blood of infants with severe RSV infection take up RSV, which
may then undergo active transcription. This evidence of direct
interaction between RSV and neutrophils in the airway and
peripheral circulation of infants with severe RSV bronchiolitis
provides fundamentally important insights into the role of in-
ﬂammatory cells recruited to the airways during infections with
respiratory viruses.
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